HENWOOD GERALDINE 4
4 · Recro Pharma, Inc. · Filed Apr 22, 2021
Insider Transaction Report
Form 4
HENWOOD GERALDINE
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-04-20+38,012→ 38,012 totalExercise: $1.71Exp: 2031-04-20→ Common Stock (38,012 underlying) - Award
Common Stock
2021-04-20+26,923→ 226,574 total
Holdings
- 50,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]All shares of common stock are represented by unvested restricted stock units that will vest on April 20, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date.
- [F2]The stock option will vest on April 20, 2022.